Role of phase 2 drug-metabolizing enzymes modulated by extracts from 78 herbal medicines in detoxification of electrophiles and lung cancer chemotherapy

  • Ohnuma Tomokazu
    Department of Drug Metabolism and Molecular Toxicology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
  • Matsumoto Takashi
    Department of Drug Metabolism and Molecular Toxicology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
  • Komatsu Takao
    Nippon Chemiphar Co. Ltd.
  • Nishiyama Takahito
    Department of Drug Metabolism and Molecular Toxicology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
  • Ogura Kenichiro
    Department of Drug Metabolism and Molecular Toxicology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
  • Iwata Hiroshi
    Mitsubishi Chemical Medience Corp.
  • Hiratsuka Akira
    Department of Drug Metabolism and Molecular Toxicology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences

Search this article

Abstract

Phase 2 drug-metabolizing enzymes (DMEs), such as glutathione S-transferase (GST) and NAD(P)H:quinone oxidoreductase 1 (NQO1), play a major role in the cellular detoxification of pharmaceutical agents and carcinogens. Previously, we reported the inhibitory effects of human liver microsomal cytochrome P450 3A4 and 2D6, phase 1 DMEs, by extracts from 78 herbal medicines. In the present study, we investigated whether phase 2 DME activity in mammalian cells was affected by the herbal extracts. Among the herbal extracts tested, GST and NQO1 activities in Clone 9 cells, a cultured cell line from normal rat liver, were increased more than 1.5-fold by treatment with Incised Notopterygium Rhizome, Magnolia Bark, Saussurea Root, and Magnolia Flower extracts. On the other hand, both of those activities were decreased to less than one-fifth by treatment with Cassia Bark and Rhubarb extracts. Pretreatment of Clone 9 cells with the former four extracts that induced phase 2 DMEs resulted in protection against the cytotoxicities of the electrophiles menadione and 1-chloro-2,4-dinitrobenzene. In contrast, GST and NQO1 activities in human lung cancer A549 cells, which are known to have a high metabolism and show resistance to anticancer drugs, was significantly decreased by treatment with the Cassia Bark extract. These results suggest that phase 2 DME activity may be modulated by herbal medicines, and the modulation of phase 2 DMEs by herbal medicines might affect the action of concomitant drugs and the detoxification of carcinogens.

Journal

Details 詳細情報について

Report a problem

Back to top